Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Dcty Biotech Co.,ltd.

Clinical trials sponsored by Beijing Dcty Biotech Co.,ltd., explained in plain language.

Not yet recruiting 1

New cell therapy targets tough cancers in early trial

Disease control Not yet recruiting

This early-phase study tests DCTY1102, a personalized cell therapy, in 18 adults with advanced colorectal, lung, or pancreatic cancers that have a specific KRAS/NRAS G12D mutation and HLA type. Participants receive a single infusion of their own genetically modified immune cells …

Phase: PHASE1 • Sponsor: Beijing DCTY Biotech Co.,Ltd. • Aim: Disease control

Last updated May 26, 2026 09:31 UTC